Sentence examples for sympathetic imaging from inspiring English sources

According to a proposal for standardization of 123I-mIBG cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology [13], all patients received 370 MBq of 123I-mIBG (AdreView, GE Healthcare, Little Chalfont, Buckinghamshire, UK) and underwent anterior planar imaging of the thorax SPECT/CT imaging of the heart at 15 min and 4 h post injection.

We have identified diastolic dysfunction early in the course of type 1 diabetes that correlated with abnormal cardiac sympathetic imaging (10).

Other methods such as cardiac sympathetic imaging, microneurography, occlusion plethysmography, and baroreflex sensitivity are currently used predominantly in research settings but may find a place in the clinical assessment of CAN in the future.

Diastolic dysfunction occurring early in the course of type 1 diabetes has been reported to be associated with abnormal cardiac sympathetic function as assessed by cardiac sympathetic imaging [ 34, 35].

Currently, cardiac sympathetic neuronal imaging has been performed most commonly with radionuclide imaging of the norepinephrine analog metaiodobenzylguanidine (MIBG) labeled with 123-iodine (123-I) [ 31– 31].

18F-N-[3-bromo-4-(3-fluoro-propoxy)-benzyl]-guanidine 18F-N-[3-bromo-4- 3-fluoro-propoxy -benzyl]-guanidineor sympathetic nervous imaging of the heart.

Simultaneous perfusion and sympathetic innervation imaging with 123I-mIBG and 99mTc-labelled tracers enables the evaluation of innervation-flow mismatch and may provide valuable information to target the trigger zone in the setting of ventricular arrhythmia [4, 26].

The single-photon emission computed tomography (SPECT) tracer 123I-meta-iodobenzylguanidine (MIBG) targeting norepinephrine transporter (NET) is currently the most widely used clinical tracer for sympathetic nervous imaging with well-established protocols and mature guidelines based on the results achieved from several clinical trials [1, 2].

In addition, sympathetic innervation imaging is increasingly used in patients with heart failure, predominantly for risk stratification.

Currently, sympathetic nerve imaging with 123-iodine metaiodobenzylguanidine (123-I MIBG) is often used for the assessment of cardiac innervation.

Anastasiou-Nana et al. [ 37] evaluated whether sympathetic nerve imaging with 123-I MIBG was predictive for adverse events in 52 patients with heart failure.